annb0t
Top 20
LONDON, UK / ACCESSWIRE / May 26, 2022 / In light of the positive newsflow from Kazia's efforts in addressing adult brain cancer, management is leveraging its niche expertise and experience to address a complex and untapped segment, childhood brain cancer. Due to the challenges in addressing this unmet need, including significant hurdles in enrolling patients for a clinical trial, there is a vacuum of options for those served with this diagnosis. As Kazia is working to pioneer this sub-segment, ...
>>> Read more: Kazia Therapeutics (KZIA): Deep Dive Into Childhood Brain Cancer
>>> Read more: Kazia Therapeutics (KZIA): Deep Dive Into Childhood Brain Cancer
